M&A Deal Summary

CX Partners Acquires Veeda Clinical Research Pvt.

On December 7, 2018, private equity firm CX Partners acquired life science company Veeda Clinical Research Pvt. from Actis Capital

Acquisition Highlights
  • This is CX Partners’ 1st transaction in the Life Science sector.
  • This is CX Partners’ 9th transaction in India.

M&A Deal Summary
Date 2018-12-07
Target Veeda Clinical Research Pvt.
Sector Life Science
Buyer(s) CX Partners
Sellers(s) Actis Capital
Deal Type Secondary Buyout

Target

Veeda Clinical Research Pvt.

Ahmedabad, India
website
Veeda Clinical Research Pvt. Ltd. is a provider of clinical studies including healthy volunteers and patient trials for Generics, NCE, and Biopharmaceuticals. Veeda Clinical Research was founded in 2004 and is based in Ahmedabad, India.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

CX Partners

New Delhi, India

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2009
PE ASSETS 625M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

CX Partners is a private equity firm specializing in middle-market growth capital and special situations investments throughout India. CX Partners was founded 2009 and is based in New Delhi.

DEAL STATS #
Overall 10 of 11
Sector (Life Science) 1 of 1
Type (Secondary Buyout) 2 of 2
Country (India) 9 of 10
Year (2018) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-04-19 bloom Hotel Group

New Delhi, India

bloom Hotel Group is an operator of a chain of hotels and restaurants providing quality hospitality services.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-21 Dindigul Thalappakatti Hotels Pvt

Chennai, India

Dindigul Thalappakatti Hotels Pvt Ltd. is a South Indian non-vegetarian restaurant chain with 64 restaurants in India and six other countries (as of December 2019). The brand has a 60-year-old heritage and is known for providing authentic, consistent, and quality food at affordable price points.

Buy -

Seller(S) 1

SELLER

Actis Capital

London, United Kingdom

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2004
PE ASSETS 24.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Actis Capital is a private equity firm focused on investments in emerging markets. Actis segments its investment activity into three areas. These include private equity, energy, and real estate. Actis' private equity team looks for buyout and growth capital opportunities requiring at least $50 million in financing. Depending on the situation, Actis will consider both controlling and minority investment situations. Sectors of interest include financial services, consumer and retail, business services, and industrial. Actis' energy group seeks to invest in in a variety of energy and utility projects. Actis' real estate team invests equity capital in office, residential, industrial, hotel and retail projects. Actis Capital was established in 2004 and is based in London.

DEAL STATS #
Overall 69 of 81
Sector (Life Science) 2 of 2
Type (Secondary Buyout) 12 of 16
Country (India) 17 of 19
Year (2018) 6 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-12 KS Distribution

Singapore, Singapore

KS Distribution is the largest oil & gas and marine products distribution business with more than 60,000 product lines across nine countries. KS Distribution was formed in 2010 and is based in Singapore.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-10 Compuscan Holdings South Africa

Stellenbosch, South Africa

Compuscan Holdings South Africa (Pty) Ltd. is a provider of total credit reporting and risk management solutions throughout the credit life-cycle. Compuscan Holdings South Africa (Pty) Ltd. was founded in 1994 and is based in Stellenbosch, South Africa.

Sell $263M
Mergr

Product

Company

Legal